Fondaparinux: A Pharmacoeconomic Review of its Use in the Management of Non-ST-Segment Elevation Acute Coronary Syndrome

By McKeage Kate   Lyseng-Williamson Katherine A.  

PharmacoEconomics, Vol. 28, Iss. 8, 2010-08 ,pp. : 687-698

Adis International

Access to resources Recommend Favorite

Evaluating the Potential ‘Economic Attractiveness’ of New Therapies in Patients with Non-ST Elevation Acute Coronary Syndrome

By Eisenstein E.L.   Peterson E.D.   Jollis J.G.   Tardiff B.E.   Califf R.M.   Knight J.D.   Mark D.B.  

PharmacoEconomics, Vol. 17, Iss. 3, 2000-03 ,pp. : 263-272

Adis International

Access to resources Recommend Favorite

Congestive heart failure complicating non-ST segment elevation acute coronary syndrome: incidence, predictors, and clinical outcomes

By Mehta Shamir R   Eikelboom John W   Demers Catherine   Maggioni Aldo P   Commerford Patrick J   Yusuf Salim  

Canadian Journal of Physiology and Pharmacology, Vol. 83, Iss. 1, 2005-01 ,pp. : 98-103

NRC Research Press

Access to resources Recommend Favorite

Paclitaxel: Acute coronary syndrome with ST-segment elevation: case report

By  

Reactions Weekly, Vol. 1, Iss. 1268, 2009-01 ,pp. : 23-24

Adis International

Access to resources Recommend Favorite

Electrocardiographic Differentiation between Acute Pulmonary Embolism and Non-ST Elevation Acute Coronary Syndromes at the Bedside

By Jankowski Krzysztof   Kostrubiec Maciej   Ozdowska Patrycja   Milanowska-Puncewicz Blanka   Pacho Szymon   Pedowska-Włoszek Justyna   Kaczyńska Anna   Łabyk Andrzej   Hrynkiewicz Anna   Pruszczyk Piotr  

Annals of Noninvasive Electrocardiology, Vol. 15, Iss. 2, 2010-04 ,pp. : 145-150

Blackwell Publishing

Access to resources Recommend Favorite